These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34751098)

  • 21. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease.
    Herstine JA; Chang PK; Chornyy S; Stevenson TJ; Sunshine AC; Nokhrina K; Rediger J; Wentz J; Vetter TA; Scholl E; Holaway C; Pyne NK; Bratasz A; Yeoh S; Flanigan KM; Bonkowsky JL; Bradbury AM
    Mol Ther; 2024 Jun; 32(6):1701-1720. PubMed ID: 38549375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
    La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
    Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult Onset Vanishing White Matter Disease: A Rare Case Report.
    Nagdev G; Vhora RS; Chavan G; Sahu G
    Cureus; 2022 Oct; 14(10):e30177. PubMed ID: 36397907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
    Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
    Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.
    Lin Y; Pang X; Huang G; Jamison S; Fang J; Harding HP; Ron D; Lin W
    J Neurosci; 2014 Sep; 34(36):12182-91. PubMed ID: 25186761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarioleukodystrophy: report of a case with the c.338G>A (p.Arg113His) mutation on exon 3 and the c.896G>A (p.Arg299His) mutation on exon 7 of the EIF2B5 gene.
    Imam I; Brown J; Lee P; Thomas PK; Manji H
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Insights in Vanishing White Matter Disease: Isolated Bilateral Optic Neuropathy in Adult Onset Disease.
    Barros SR; Parreira SCR; Miranda AFB; Pereira AMB; Campos NMP
    J Neuroophthalmol; 2018 Mar; 38(1):42-46. PubMed ID: 28902089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5.
    Ohtake H; Shimohata T; Terajima K; Kimura T; Jo R; Kaseda R; Iizuka O; Takano M; Akaiwa Y; Goto H; Kobayashi H; Sugai T; Muratake T; Hosoki T; Shioiri T; Okamoto K; Onodera O; Tanaka K; Someya T; Nakada T; Tsuji S
    Neurology; 2004 May; 62(9):1601-3. PubMed ID: 15136690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy.
    Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F
    Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eIF2B-related multisystem disorder in two sisters with atypical presentations.
    Lee JS; Lee S; Choi M; Lim BC; Choi J; Kim KJ; Cheon JE; Kim IO; Chae JH
    Eur J Paediatr Neurol; 2017 Mar; 21(2):404-409. PubMed ID: 28041799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5.
    Matsukawa T; Wang X; Liu R; Wortham NC; Onuki Y; Kubota A; Hida A; Kowa H; Fukuda Y; Ishiura H; Mitsui J; Takahashi Y; Aoki S; Takizawa S; Shimizu J; Goto J; Proud CG; Tsuji S
    Neurogenetics; 2011 Aug; 12(3):259-61. PubMed ID: 21484434
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.
    Wu Y; Pan Y; Du L; Wang J; Gu Q; Gao Z; Li J; Leng X; Qin J; Wu X; Jiang Y
    J Hum Genet; 2009 Feb; 54(2):74-7. PubMed ID: 19158808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response.
    Keefe MD; Soderholm HE; Shih HY; Stevenson TJ; Glaittli KA; Bowles DM; Scholl E; Colby S; Merchant S; Hsu EW; Bonkowsky JL
    Elife; 2020 Dec; 9():. PubMed ID: 33300869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic analysis of CSF1R-related leukoencephalopathy on magnetic resonance imaging: a case report.
    Huang H; Cao L; Chen H
    BMC Neurol; 2021 Apr; 21(1):156. PubMed ID: 33838643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant form of vanishing white matter-like leukoencephalopathy.
    Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
    Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The disappearance of white matter in an adult-onset disease: a case report.
    Ho CS; Mangelsdorf S; Walterfang M
    BMC Psychiatry; 2020 Mar; 20(1):137. PubMed ID: 32220229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
    Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
    Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype-phenotype correlation in vanishing white matter disease.
    van der Lei HD; van Berkel CG; van Wieringen WN; Brenner C; Feigenbaum A; Mercimek-Mahmutoglu S; Philippart M; Tatli B; Wassmer E; Scheper GC; van der Knaap MS
    Neurology; 2010 Oct; 75(17):1555-9. PubMed ID: 20975056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.